Reports
Reports
Sale
The global chronic disease management market size was valued at USD 7.66 billion in 2023, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 14.4% during the forecast period of 2024-2032, with values likely to rise from USD 8.77 billion in 2024 and to USD 25.72 billion by 2032.
Chronic diseases refer to health conditions that persist over a long period of time. They can last for years or even a lifetime. Chronic diseases are responsible for more than 41 million people every year, almost 75% of the deaths globally. Nearly 17 million people across the world die from chronic diseases before the age of 70 years. Out of these deaths, about 86% of the deaths are registered in low- and middle-income regions. Among these deaths, cardiovascular diseases accounts for the highest number of deaths, almost 17.9 million deaths every year. Cardiovascular diseases are followed by cancers, responsible for over 9.3 million deaths, chronic respiratory diseases accounting for about 4.1 million deaths, and diabetes and kidney related disorders associated with diabetes, accounting for over 2 million deaths annually. These diseases are responsible for more than 80% of premature deaths every year. The key factors contributing to the increasing prevalence of chronic diseases include the rising use of tobacco and alcohol, lack of physical activities, unhealthy diets, and pollution levels.
With the increasing prevalence of chronic disorders, the demand for disease management has also increased. The chronic disease management market demand can be attributed to factors like rising support from the governments, rising investment in research and development of advanced and efficient treatments, and technological advancements, among others.
Governments across the world are supporting chronic disease management market growth by introducing various acts and initiatives to increase public awareness. For instance, in March 2023, Chronic Disease Management Act (CDMA) was introduced in the United States Senate. This bill is an expansion on previous versions of CDMA and follows the 2019 guidance issued by the U.S. Department of Treasury to further increase the flexibility of HSA-HDHPs to cover chronic disease services on a pre-deductible basis.
The significant increase in the research and development of new drugs for adults suffering from chronic disease have been propelling the market growth. In the past few years, there have been major clinical trials and drug approvals, which has significantly reformed the healthcare sector. Such efforts are anticipated to continue bolstering growth in the coming years as well. For instance, Alzheon, Inc. is conducting a trial on ALZ-801, an amyloid beta-protein inhibitor, is in phase III trial for adult patients suffering from Alzheimer’s disease. It sparks hope for the overall industry as the condition is barely treatable. Notable efforts in the research and development of treatments for such conditions are likely to aid the chronic disease management market demand.
The market has been witnessing significant technological advancements over the past few years and artificial intelligence has been a breakthrough for the entire world. The integration of genome, epigenome, microbiome data, among others multi-omics data can prove to be powerful method of studying and analysing these complex diseases and help in developing effective treatment methods.
Constant efforts are being made in the industry to develop innovative technologies, which are likely to contribute significantly to the chronic disease management market share. For instance, in September 2023, the National Institutes of Health (NIH) introduced their BRAIN Initiative. This initiative is aimed at developing data and tools that can help in better understanding of the brain circuit functioning and to lay the foundation that can help diagnose the brain conditions more precisely.
Artificial intelligence, on the other hand, has also found wide applications in the market as it effectively reduces time of development, leading to early diagnosis and early-stage discovery of effective drugs. Constant developments in AI are also likely to aid the market growth in the coming years. In June 2023, the World Economic Forum launched the 2023 report on Technology Pioneers named 'Top 10 Emerging Technologies of 2023’. In this report, significant emphasis was laid on the importance of AI in the future of various industries, including healthcare industry. AI can help in speeding up the process of drug and vaccine approval, along with enhancing the diagnosis and treatment procedures, which will eventually benefit the healthcare industry to a large extent.
Market Breakup by Type
Market Breakup by Solution Type
Market Breakup by Service Type
Market Breakup by Disease Indication
Market Breakup by End User
Market Breakup by Region
North America, especially the United States, is likely to lead the global market during the forecast period due to the presence of a geriatric population and the increasing adoption of a sedentary lifestyle leading to chronic diseases. The growth of the market can be attributed to the higher presence of key players in the region. The region has been witnessing rapid developments and is likely to continue dominating the chronic disease management market size.
The number of drug approvals by the US FDA has also increased significantly. For instance, in September 2023, Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced that the US FDA approved Jardiance® (empagliflozin) 10 mg tablets. These tablets will have wide application in the treatment of chronic kidney disorders.
News and Development
In March 2023, Royal Philips (NYSE: PHG) announced the launch of Philips Virtual Care Management. It would offer a portfolio of various services and solutions that will make the process of health systems, providers, employers, and payers much easier. It would also help the physicians connect with the patients virtually from anywhere in the world. The system would significantly reduce the pressure on hospital and staff by reducing the number of emergency visits since they can be consulted virtually. It would be a cost-efficient alternative for the patients, therefore likely to witness significant demand in the coming years.
In October 2023, WellSky acquired Corridor, which is an end-to-end enable services platform, known to deal with pots-acute challenges faced in the industry. Wellsky acquired the latter from HealthEdge Investment Partners, which is a private equity firm working in the healthcare industry. With this acquisition, WellSky will be able to expand its footprint in medical coding as well as and revenue cycle management (RCM). The company will then be able to offer better services to the patients.
The key features of the chronic disease management market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Solution Type |
|
Breakup by Service Type |
|
Breakup by Disease Indication |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Chronic Disease Management Market Overview
3.1 Global Chronic Disease Management Market Historical Value (2017-2023)
3.2 Global Chronic Disease Management Market Forecast Value (2024-2032)
4 Global Chronic Disease Management Market Landscape
4.1 Global Chronic Disease Management: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Chronic Disease Management: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Chronic Disease Management Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Chronic Disease Management Market Segmentation
6.1 Global Chronic Disease Management Market by Type
6.1.1 Market Overview
6.1.2 Solution
6.1.3 Services
6.2 Global Chronic Disease Management Market by Solution Type
6.2.1 Market Overview
6.2.2 On-Premises Solution
6.2.3 Cloud-Based Solution
6.2.4 Web-Based
6.3 Global Chronic Disease Management Market by Service Type
6.3.1 Market Overview
6.3.2 Educational Service
6.3.3 Implementation Service
6.3.4 Consulting Service
6.3.5 Others
6.4 Global Chronic Disease Management Market by Disease Indication
6.4.1 Market Overview
6.4.2 Cardiovascular Diseases (CVD)
6.4.3 Diabetes
6.4.4 Chronic Obstructive Pulmonary Disorders (COPD)
6.4.5 Arthritis
6.4.6 Asthma
6.4.7 Cancer
6.4.8 Others
6.5 Global Chronic Disease Management Market by End User
6.5.1 Market Overview
6.5.2 Healthcare Providers
6.5.3 Healthcare Payers
6.5.4 Others
6.6 Global Chronic Disease Management Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Chronic Disease Management Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Chronic Disease Management Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Global Chronic Disease Management Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Chronic Disease Management Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Chronic Disease Management Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 WellSky
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 ZeOmega
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Health Catalyst
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cedar Gate Technologies
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Cognizant
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Pegasystems Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Epic Systems Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Hinduja Global Solutions Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 NXGN Management, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 MINES & Associates, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Koninklijke Philips N.V
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Vivify Health, Inc
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Allscripts Healthcare, LLC
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Casenet, LLC
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 7.66 billion in 2023, driven by increasing prevalence of chronic diseases across the globe.
The market is anticipated to grow at a CAGR of 14.4% during the forecast period of 2024-2032, likely to reach a market value of USD 25.72 billion by 2032.
The market demand is driven by the growing prevalence of chronic diseases, rising technological advancements in the market, mergers and acquisitions, along with the rising disposable incomes of the consumers.
The current market trend involves the rising support from the government in the form of initiatives and investments in research and development of new drugs and technologies.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
The key players in the market include WellSky, ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management, LLC, MINES & Associates, Inc., Koninklijke Philips N.V, Vivify Health, Inc, Allscripts Healthcare, LLC, and Casenet, LLC.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.